Search

Your search keyword '"Althoff, Keri N"' showing total 23 results
Start Over Author "Althoff, Keri N" Journal jaids: journal of acquired immune deficiency syndromes
23 results on '"Althoff, Keri N"'

1. Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV.

Author

Coburn, Sally B., Pimentel, Noel, Leyden, Wendy, Kitahata, Mari M., Moore, Richard D., Althoff, Keri N., Gill, M. John, Lang, Raynell, Horberg, Michael A., D'Souza, GypsyAmber, Hussain, Shehnaz K., Dubrow, Robert, Novak, Richard M., Rabkin, Charles S., Park, Lesley S., Sterling, Timothy R., Neugebauer, Romain S., Silverberg, Michael J., Benson, Constance A., and Bosch, Ronald J.

Published
2024
Full Text
View/download PDF

9. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.

Author

Lo, Re, Vincent III MD, MSCE, Newcomb, Craig W. MS, Carbonari, Dena M. MS, Roy, Jason A. PhD, Althoff, Keri N. PhD, Kitahata, Mari M. MD, MPH, Reddy, K. Rajender MD, Lim, Joseph K. MD, Silverberg, Michael J. PhD, MPH, Mayor, Angel M. MD, MS, Horberg, Michael A. MD, MAS, Cachay, Edward R. MD, MAS, Kirk, Gregory D. MD, MPH, PhD, Hull, Mark MD, Gill, John MB, ChB, MSc, Sterling, Timothy R. MD, Kostman, Jay R. MD, Peters, Marion G. MD, Moore, Richard D. MD, and Klein, Marina B. MD, MSc

Published
2019
Full Text
View/download PDF

13. Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV.

Author

Elion, Richard A., Althoff, Keri N., Jinbing Zhang, Moore, Richard D., Gange, Stephen J., Kitahata, Mari M., Crane, Heidi M., Drozd, Daniel R., Stein, James H., Klein, Marina B., Eron, Joseph J., Silverberg, Michael J., Mathews, William C., Justice, Amy C., Sterling, Timothy R., Rabkin, Charles S., Mayor, Angel M., Klein, Daniel B., Horberg, Michael A., and Bosch, Ronald J.

Abstract

Background: There is persistent confusion as to whether abacavir (ABC) increases the risk of myocardial infarction (MI), and whether such risk differs by type 1 (T1MI) or 2 (T2MI) MI in adults with HIV. Methods: Incident MIs in North American Cohort Collaboration on Research and Design participants were identified from 2001 to 2013. Discrete time marginal structural models addressed channeling biases and time-dependent confounding to estimate crude hazard ratio (HR) and adjusted hazard ratio (aHR) and 95% confidence intervals; analyses were performed for T1MI and T2MI separately. A sensitivity analysis evaluated whether Framingham risk score (FRS) modified the effect of ABC on MI occurrence. Results: Eight thousand two hundred sixty-five adults who initiated antiretroviral therapy contributed 29,077 person-years and 123 MI events (65 T1MI and 58 T2MI). Median follow-up time was 2.9 (interquartile range 1.4-5.1) years. ABC initiators were more likely to have a history of injection drug use, hepatitis C virus infection, hypertension, diabetes, impaired kidney function, hyperlipidemia, low (<200 cells/mm³) CD4 counts, and a history of AIDS. The risk of the combined MI outcome was greater for persons who used ABC in the previous 6 months [aHR = 1.84 (1.17-2.91)]; and persisted for T1MI (aHR = 1.62 [1.01]) and T2MI [aHR = 2.11 (1.08-4.29)]. FRS did not modify the effect of ABC on MI (P = 0.14) and inclusion of FRS in the MSM did not diminish the effect of recent ABC use on the combined outcome. Conclusions: Recent ABC use was associated with MI after adjustment for known risk factors and for FRS. However, screening for T1MI risks may not identify all or even most persons at risk of ABC use-associated MIs. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

16. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

Author

Drozd, Daniel R., Kitahata, Mari M., Althoff, Keri N., Jinbing Zhang, Gange, Stephen J., Napravnik, Sonia, Burkholder, Greer A., Mathews, William C., Silverberg, Michael J., Sterling, Timothy R., Heckbert, Susan R., Budoff, Matthew J., Van Rompaey, Stephen, Delaney, Joseph A. C., Cherise Wong, Weiqun Tong, Palella, Frank J., Elion, Richard A., Martin, Jeffrey N., and Brooks, John T.

Published
2017
Full Text
View/download PDF

17. Association of CD4+ T-cell Count, HIV-1RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.

Author

Dubrow, Robert, Li Qin, Haiqun Lin, Hernández-Ramírez, Raúl U., Neugebauer, Romain S., Leyden, Wendy, Althoff, Keri N., Achenbach, Chad J., Hessol, Nancy A., Modur, Sharada P., D'Souza, Gypsyamber, Bosch, Ronald J., Grover, Surbhi, Horberg, Michael A., Kitahata, Mari M., Mayor, Angel M., Novak, Richard M., Rabkin, Charles S., Sterling, Timothy R., and Goedert, James J.

Published
2017
Full Text
View/download PDF

19. Impact of Age on Retention in Care and Viral Suppression.

Author

Yehia, Baligh R., Rebeiro, Peter, Althoff, Keri N., Agwu, Allison L., Horberg, Michael A., Samji, Hasina, Napravnik, Sonia, Mayer, Kenneth, Tedaldi, Ellen, Silverberg, Michael J., Thorne, Jennifer E., Burchell, Ann N., Rourke, Sean B., Rachlis, Anita, Mayor, Angel, Gill, Michael J., Zinski, Anne, Ohl, Michael, Anastos, Kathryn, and Abraham, Alison G.

Published
2015
Full Text
View/download PDF

20. Understanding the Disparity.

Author

McFall, Allison M., Dowdy, David W., Zelaya, Carla E., Murphy, Kerry, Wilson, Tracey E., Young, Mary A., Gandhi, Monica, Cohen, Mardge H., Golub, Elizabeth T., and Althoff, Keri N.

Published
2013
Full Text
View/download PDF

21. Retention Among North American HIV-Infected Persons in Clinical Care, 2000-2008.

Author

Rebeiro, Peter, Althoff, Keri N., Buchacz, Kate, Gill, John, Horberg, Michael, Krentz, Hartmut, Moore, Richard, Sterling, Timothy R., Brooks, John T., Gebo, Kelly A., Hogg, Robert, Klein, Marina, Martin, Jeffrey, Mugavero, Michael, Rourke, Sean, Silverberg, Michael J., Thorne, Jennifer, and Gange, Stephen J.

Abstract

Retention in care is key to improving HIV outcomes. The goal of this study was to describe "churn" in patterns of entry, exit, and retention in HIV care in the United States and Canada.Adults contributing ≥1 CD4 count or HIV-1 RNA (HIV-lab) from 2000 to 2008 in North American AIDS Cohort Collaboration on Research and Design clinical cohorts were included. Incomplete retention was defined as lack of 2 HIV-laboratories (≥90 days apart) within 12 months, summarized by calendar year. Beta-binomial regression models were used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) of factors associated with incomplete retention.Among 61,438 participants, 15,360 (25%) with incomplete retention significantly differed in univariate analyses (P < 0.001) from 46,078 (75%) consistently retained by age, race/ethnicity, HIV risk, CD4, antiretroviral therapy use, and country of care (United States vs. Canada). From 2000 to 2004, females (OR = 0.82, CI: 0.70 to 0.95), older individuals (OR = 0.78, CI: 0.74 to 0.83 per 10 years), and antiretroviral therapy users (OR = 0.61, CI: 0.54 to 0.68 vs. all others) were less likely to have incomplete retention, whereas black individuals (OR = 1.31, CI: 1.16 to 1.49, vs. white), those with injection drug use HIV risk (OR = 1.68, CI: 1.49 to 1.89, vs. noninjection drug use), and those in care longer (OR = 1.09, CI: 1.07 to 1.11 per year) were more likely to have incomplete retention. Results from 2005 to 2008 were similar.From 2000 to 2008, 75% of the North American AIDS Cohort Collaboration on Research and Design population was consistently retained in care with 25% experiencing some changes in status or churn. In addition to the programmatic and policy implications, the findings of this study identify patient groups who may benefit from focused retention efforts. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results